Back to Search
Start Over
Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
- Source :
- JAMA Cardiology; Sep2022, Vol. 7 Issue 9, p914-923, 10p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 23806583
- Volume :
- 7
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- JAMA Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 159158906
- Full Text :
- https://doi.org/10.1001/jamacardio.2022.2006